Summary We have developed a new technique to measure in vivo tumour tissue fluid transport parameters (hydraulic conductivity and compliance) that influence the systemic and intratumoral delivery of therapeutic agents. An infusion needle approximating a point source was constructed to produce a radially symmetrical fluid source in the centre of human tumours in immunodeficient mice. At constant flow, the pressure gradient generated in the tumour by the infusion of fluid (Evans blue-albumin in saline) was measured as a function of the radial position with micropipettes connected to a servo-null system. To evaluate whether the fluid infused was reabsorbed by blood vessels, infusions were also performed after circulatory arrest. In the colon adenocarcinoma LS174T with a spherically symmetrical distribution of Evans blue-albumin, the median hydraulic conductivity in vivo and after circulatory arrest at a flow rate of 0.1 ,ul min-' was, respectively, 1 .7x1 0-7 and 2.3x1 0-7 cm2 mmHg-' s. Compliance estimates were 35 gl mmHg-' in vivo, and 100 ,ul mmHg-' after circulatory arrest In the sarcoma HSTS 26T, hydraulic conductivity and compliance were not calculated because of the asymmetric distribution of the fluid infused. The technique will be helpful in identifying strategies to improve the intratumoral and systemic delivery of gene targeting vectors and other therapeutic agents.
sient state of infusion, because C is involved in the process. To uncouple K from C, the measurements for K must be performed in steady-state conditions (Swabb et al, 1974; Ford et al, 1991; Tokita and Tanaka, 1991) .
The goal of the present study was, therefore, to develop a new technique to estimate K in solid tumours, in vivo, at steady state and with a good spatial resolution. To this end, fluid (Evans blue-albumin in saline) was infused at low flow rates into the centre of a tumour with a special needle approximating a point source. The pressure increased gradually during fluid infusion and reached a plateau, indicating the attainment of steady state. At steady state, the pressure was measured at known distances from the source with a micropipette connected to a servo-null device. K and C were estimated in tumours with a spherically symmetrical distribution of the fluid infused as determined by the distribution of Evans blue albumin. In the sarcoma HSTS 26T, the distribution of Evans blue was asymmetric. K and C were estimated in LS 1 74T following the confirmation of a spherically symmetrical fluid distribution. C was estimated from the time constant required for the equilibrium of the infusion pressure.
MATERIALS AND METHODS

Animals and tumours
Eight-to ten-week-old athymic NCr/Sed-nu/nu mice from the Edward L Steele Laboratory animal facility were used. The mice *Supported by an NCI Outstanding Investigator Award (R35 CA5659 1) to RKJ and by fellowships from Homans Legat and the Norwegian Research Council to CB. The first two authors (YB and CB) contributed equally to this work. The needle was constructed from a 22-gauge needle and a thin steel wire. The sharp tip of a 22-gauge needle was cut and glued to one end of the steel wire. The other end of the steel wire was placed in the 22-gauge cylinder. A fixed opening of approximately 0.7 mm was produced between the tip and cylinder by bending the wire perpendicular to the main axis of the needle. PE 50 tubing was used to stabilize the opening between the tip and cylinder, and for connection with the infusion pump and pressure transducer. B Schematic diagram of the experimental set-up. The point-source needle (1) was placed in the centre of the tumour (radius R) and fluid infused at a constant flow rate. Steady-state radial pressure profiles were measured with high spatial resolution using a glass micropipette (2) in a region 0.3-2.0 mm from the edge of the infusion needle (3) were fed sterilized rodent food and water ad libitum. Two human tumours, the colon adenocarcinoma LS 1 74T and the sarcoma HSTS 26T, were implanted subcutaneously in the leg of each mouse. K was estimated when the tumours had reached a volume between 200 and 500 mm3.
Infusion needle
To infuse fluid into the centre of a tumour, an infusion needle was constructed to produce a spherically symmetrical fluid source ( Figure 1A) . A very thin stainless-steel wire (35 mm long) was fixed to the sharp portion (2 mm in length) of a 22-gauge needle with epoxy glue. The other end of the wire was introduced in the lumen of a 22-gauge cylinder. A fixed opening of approximately 0.7 mm in length between the sharp portion and the 22-gauge cylinder was produced by bending the wire perpendicular to the main axis of the needle. To fix the opening between the sharp portion and the cylinder, PE-50 tubing was attached to the cylinder. The needle and the PE 50 tubing were glued to a Plexiglas arm mounted on a graded micromanipulator, which was used for controlling the depth of needle insertion. To measure the pressure of infusion, the needle was connected to the side port of the dome of a pressure transducer (Statham 23b, Spectramed, Oxnard, CA, USA) by the PE-50 tubing, and another side port on the dome was connected by PE 50 tubing to a l-ml syringe controlled by a constant flow infusion pump (Pump 22, Harvard Apparatus, South Natick, MA, USA). The compliance of the pressure transducer infusion pump setup was 0.04 ,ul mmHg-'.
Pressure measurements
The pressure was measured with micropipettes and a servo-null device as previously described previously (Boucher et al, 1990; Boucher and Jain, 1992) . To prepare the micropipettes, thick-wall capillary tubing (0.86 mm outer diameter, 0.38 mm inner diameter) was pulled with a micropipette puller. Micropipettes with a tip diameter between 2 and 4 gm were filled by capillarity with a 1 M sodium chloride solution prepared from filtered, distilled, deionized water.
The micropipettes and the servo-null device were used to measure the baseline interstitial fluid pressure (IFP) profiles in the tumour as well as the pressure profiles generated by the low flow rate infusions. A graded micromanipulator was used to insert micropipettes at known depths from the tumour surface. The pressure was measured for periods of 25-50 s, once a patent fluid communication between the tissue and micropipette was established. The following criteria were used to validate the measurements: (a) the fluid communication between the micropipette and the tissue was confirmed electrically, (b) the pressure remained stable after varying the feedback gain of the system and (c) the zero pressure in saline at the tumour surface did not change during the measurements.
Experimental procedure
During fluid infusion into the tumour centre, there is a transient redistribution of fluid. This phenomenon is controlled by K and the C of the tissue. At steady state, the steepness of the pressure profile around the infusion site is controlled by K only. Therefore, it is possible to evaluate K by measuring the pressure profile generated by the intratumoral infusion.
The mice were anaesthetized with ketamine/xylazine (90/ 10 mg kg-'). During all procedures, mice were placed on a temperature-regulated heating pad and the body temperature was maintained between 36°C and 37°C. To minimize the deformation of the tumour during the insertion of the infusion needle, a small skin incision was made. The insertion depth of the needle was controlled by the moving arm of a graded micromanipulator. Before the infusion, the baseline IFP in the tumour was measured with micropipettes. To estimate K in LS 174T, 5% albumin and 0.25% Evans blue in saline (0.9%) were infused at a rate of 0.10 or 0.14 gl min-' with the infusion pump. Because of the low compliance of HSTS 26T, infusions were made at a flow rate of 0.05 Rtl min-' in that tumour. The steady-state pressure profile induced by the infusion needle was measured with micropipettes ( Figure 1B) . With a reference mark on the infusion needle, the micropipette was inserted close to the infusion source at an angle of 450 with a graded micromanipulator under stereomicroscopic the region close to the source is characterized by flow irregularities. To evaluate whether tumour blood vessels reabsorbed the fluid infused, K was estimated after circulatory arrest by sacrificing the animals.
Distribution of the Evans blue-albumin complex
The assumption of a spherical distribution of the infusion solution was evaluated following the completion of the measurements. The tumour was cut in the centre, and 2-3 mm anterior and posterior to the fluid source.
Measurement of water content
To evaluate whether the infusion volume significantly modified the water content in the tumour, we compared the water content of tumours infused in vivo and tumours without infusion. After the infusion of 8 ,ul of saline, a 3-mm-thick slice from the infusion region was obtained from the centre of five tumours, and cut to obtain a piece of tissue of 3x3x3 mm. A similar piece of tissue was also obtained from the centre of five tumours that were not infused. The wet weight (Tw) was measured immediately after cutting. The dry weight (Td) was measured 24 and 48 h after drying at 50°C. The tumour water content (T ) was calculated as
Histology
At the end of the infusion, the animals were sacrificed. The leg with the tumour was dissected from the animal, being careful not to move the needle in the tumour. The tumours with the needle were placed in fixative solution (formaldehyde 3.5%, methanol 1.5%) for 2-3 days. To examine the infused area, the tumour was cut in half and two tissue slices (2 mm thick) were then obtained from each side of the central cut. The tissue was processed for histology and embedded in the plastic resin JB4. Tissue sections
(1-2 gm thick) were obtained and stained with toluidine blue.
Data analysis K was estimated by applying Darcy's law for flow through a porous medium (Baxter and Jain, 1989) , normalized (viscosity 5% albumin in isotonic saline/viscosity isotonic saline) at 20°C for comparison with literature values (Levick, 1987) . Furthermore, we estimated tissue compressibility from the time constant of the pressure transients (Basser, 1992 (1) RESULTS where u is the fluid velocity and Vp is the pressure gradient. Based on the experimental data, the baseline IFP was considered constant throughout the tumour. The radial steady-state pressure profile during infusion was fitted for estimation of K using this Darcy's law model
(2) where P(r), is the pressure at radial position r, P0 is the baseline IFP, Q is the constant flow rate and R is the tumour radius. A regional distribution of K was obtained from contiguous points in the induced pressure gradients, using the differential form of the theoretical profile.
The mean radial position was taken as (r, + r2)/2. Only pressure measurements which were 1 mmHg above the baseline plateau pressure were included in the differential analysis. The values of K obtained were considered as average tissue K-values and were
To estimate K, we verified the assumption that spherically symmetrical fluid flow occurred. After infusions, the tumours were cut to evaluate the distribution of the Evans blue-albumin complex. In HSTS 26T, the distribution of Evans blue was asymmetric. The non-uniform distribution was observed in the region of infusion or as a significant accumulation of Evans blue separated from the infusion site (Figure 2A ). Histological examination of tumour slices revealed that in some tumours the accumulation of Evans blue at some distance from the infusion site was associated with necrotic regions. In other HSTS 26T tumours, the distribution of Evans blue was associated with viable tumour tissue, and it was impossible to characterize the causes of the asymmetric distribution of the Evans blue-albumin complex. In contrast, in LS174T tumours at flow rates of 0.1 or 0.14 tl min-' the dye occupied, after approximately 90 min, a circular region of 2.5-4.0 mm in the centre of most tumours, thus confirming the assumption that spherically symmetrical fluid flow occurred ( Figure 2B ). The main mode of transport was, thus, bulk flow. The K= (Q/4n)[(r2-r1)Ir,r2] [P(rl)-P(r2)]. The mean radial position was taken as (rl+r2)/2. Note that, at this flow rate, neither in vivo (0; n = 8) nor after CA (0; n = 7) do the data suggest any radial dependence of K arrest. At a flow rate of 0.1 ,gl min-', by both types of analysis, the median K-values were less in vivo compared with circulatory arrest; however, the differences were not significant (Table 1) (Boucher et al, 1990; Boucher and Jain, 1992) . In the LS 174T tumour, the IFP was also uniform in the centre and dropped close to the surface. The median tumour IFP in vivo was 14.0 mmHg (range 7-23.5). The placement of the infusion needle in the tumour did not modify the steady-state IFP profiles. Figure 3 shows typical changes in the infusion needle pressure in a tumour during infusion in vivo, at a rate of 0.10 ,ul min-'. The infusion pressure reached steady state within 25-60 min, with a time constant of 7-18 min. The pressure profile induced by the infusion was measured at steady state (Figure 4) . At 0.3-0.5 mm from the infusion source, the pressure measured with micropipettes was 3-12 mmHg higher than the baseline IFP in the tumour before the infusion. The pressure dropped to the baseline IFP value in the tumours within a radius of 1-2 mm from the source.
In LS 174T, at a flow rate of 0.1 p1l min-', median K in vivo was 1.7 x 10-7 cm2 mmHg-' s, both by differential analysis and by least squares non-linear regression of the theoretical profile to the measured pressure profile. After circulatory arrest, median K by differential analysis was 2.8 x 10-' and from a fit to the complete profile 2.3 x 10-7 (Table 1) . No significant differences were found by estimating K by differential analysis or by fitting the complete profile (Table 1) . Because of the high hydraulic permeability of the tumour vasculature (Sevick and Jain, 1991) , we expected that the fluid infused would be reabsorbed in part by the blood vessels, thus the estimate of K in vivo could be an overestimate. To evaluate whether fluid was reabsorbed, K was measured after circulatory K has been measured with in vitro and in vivo techniques. Two approaches are used to measure K in vitro: the measurement of fluid extrusion from tissue under compression or by applying a pressure head across a tissue slice of known thickness. With in vitro techniques, the influence of compression and hydration on the measurements of K have to be considered (Levick, 1987) . K in vivo is obtained from the measurement of fluid velocity resulting from a natural or an applied pressure gradient (Guyton et al, 1966; Swabb et al, 1974; Levick, 1979; DiResta et al, 1993) . Most in vivo measurements of K are limited by the poor definition of geometric dimensions and by difficulties in separating K from C. The present technique measures with micropipettes the radial pressure profile generated by a constant-flow infusion. The resolution provided by micropipettes permits precise determinations of the distance between the infusion source and the tip of the micropipette. Measurements of K in vivo or after circulatory arrest are made at steady state, the contribution of C is, thus, negligible. K can be measured by differential analysis at different radial positions from the infusion needle or by fitting the complete pressure profile. Because the technique is dependent on the spherically symmetrical distribution of the fluid infused, heterogeneity in fluid flow limits the determination of K (e.g. HSTS 26T tumour). Potentially, K could be estimated from the pressure in the infusion needle. This estimation would be less accurate because it is not possible to determine precisely the size of the cavity (needle radius + tissue displacement). A small error in the estimation of this dimension would lead to a big error in the K estimation.
A potential limitation of the present and also of previous in vivo techniques estimating K is the possibility that the fluid infused could be reabsorbed by blood or lymphatic vessels (Guyton et al, 1966; Levick, 1980) . We addressed the issue of reabsorption by estimating K in vivo and after circulatory arrest. Mellander (1960) demonstrated that fluid reabsorption in the hind limb microcirculation ceased completely within 1 min of circulatory arrest. Recent data suggest that this is also the case in tumours (Netti et al, 1995 Hydraulic conductivity of solid tumours 1447 after circulatory arrest, thus suggesting that reabsorption of the fluid infused is minimal or zero in the LS174T tumour. A possible reason why reabsorption was not significant in vivo could be because of local properties in the region of the infusion. The infusions were done in the tumour centre. Generally, vascular density and blood flow in experimental tumours are reduced in the centre compared with peripheral regions (Thompson et al, 1987; Jirtle, 1988; Tozer et al, 1990) . However, in the region surrounding the infusion needle, blood vessels were observed on histological slides. In some cases, the blood vessels appeared congested with red blood cells suggesting a stagnant flow. If blood perfusion was stopped in the vicinity of the needle, reabsorption would be minimal and most of the fluid would be transported by bulk flow through the interstitial matrix. The fact that K-values were similar in vivo and after circulatory arrest in LS174T tumours demonstrates that K can be measured in two different types of preparations without being modified. However, this cannot be a general rule, it is possible that in other tumour types K estimates could be significantly different in vivo and after circulatory arrest. If K is estimated in vivo, it should also be measured after circulatory arrest to determine whether reabsorption is significant.
Several studies have shown that K is modified by tissue hydration (Guyton et al, 1966; Fatt, 1968; Zawieja et al, 1992 (Levick, 1987; Lai Fook et al, 1989) . Swabb et al (1974) reported the first measurements of K for tumour tissue, K in vitro for a slice of rat hepatoma (0.3 x 107 cm2/mmHg/s) was fivefold higher than in normal subcutaneous tissue. Our in vivo values of K (1.7 x 10-7) for the colon adenocarcinoma LS 174T are almost sixfold higher than K for slices of rat hepatoma. In another study with the same tumour (LS 174T), we found that K in vitro (2.4 x 10-7cm2/mmHg/s) measured with a flow chamber was comparable to the present in vivo values (C Znati, Y Boucher and RK Jain, unpublished data). Swabb et al (1974) also estimated Kin vivo by measuring the unsteady flow from micropore chambers embedded in a subcutaneous tumour, and reported values that were tenfold lower than their in vitro values. Because of the uncertainty in the calculations to obtain K, it is possible that their in vivo values were not accurate, as acknowledged by Swabb et al (1974) .
In a recent study, DiResta et al (1993) calculated from IFP gradients and bulk flow measurements a K-value of 59xlO-7 cm2/ mmHg/s in a human neuroblastoma transplanted into immunodeficient animals.
Estimation of C and implication for estimation of Lp
By estimating K in vivo at steady state with the present technology, it would be possible to estimate other fluid transport parameters.
The transient evolution of the infusion pressure (Figure 3) is controlled by the product of C and K (Ford et al, 1991; Basser, 1992) . From the estimate of the time constant of this evolution and K, it is possible to estimate compressibility and C (Table 1) . Because these measurements of compressibility and C are highly dependent on the assumptions and the formulation used to calculate them, they have to be considered as first order approximations. A better estimate could be provided by a proper mathematical model that would describe more accurately the transient phenomena.
The steepness of the baseline IFP profiles in tumours can be defined by the parameter oc& (Jain and Baxter, 1988; Baxter and Jain, 1989 Implications for systemic and intratumoral delivery of therapeutic agents
The tissue hydraulic conductivity (K) is a key determinant of the systemic and intratumoral delivery of therapeutic agents. A relatively low K can contribute to the elevated IFP which has been associated with the poor accumulation of macromolecules (e.g. monoclonal antibodies) in tumours (Sands, 1992; Jain, 1993) . We previously demonstrated that the IFP profiles in experimental tumours were uniform throughout the tumour and dropped steeply in the periphery (Boucher et al, 1990) . In a mathematical model for fluid transport in solid tumours, the ratio of LpIK was identified as a determinant of the steepness of the IFP profiles (Jain and Baxter, 1988; Baxter and Jain, 1989) . In a subsequent study, we found that the superficial microvascular pressure was similar to the central IFP, whereas in the tumour periphery the microvascular pressure was significantly higher than the IFP (Boucher and Jain, 1992) . The IFP distribution in tumours suggests that fluid filtration is negligible in the centre and high in the periphery. Because extravasation of macromolecules and filtration of fluids are potentially coupled, this could explain the poor accumulation of macromolecules in the central areas of tumours (Jain and Baxter, 1988; Baxter and Jain, 1989) . A large increase in K could reduce the IFP in the centre of tumours and, thus, increase the filtration of fluids and the extravasation of macromolecules.
To improve the penetration of monoclonal antibodies, gene vectors and other therapeutic agents in normal or tumour tissues, interstitial infusion methods have been developed Morrison et al, 1994; Order et al, 1994) The present technique is able to characterize key determinants (K, compliance, pressure gradients and reabsorption) that will influence the success of intratumoral infusions. If K is elevated, a uniform distribution of the infused drug throughout the tumour would be expected. However, if K is very low, the enhancement provided by intratumoral infusion may be less. As K decreases the volume of tissue penetrated by fluid will reduce to a small region around the infusion source. Heterogeneity in K or in compliance could result in the asymmetric distribution of therapeutic agents or other molecules that are infused into the tumour. Significant differences in the distribution of Evans blue-albumin were found between HSTS 26T and LS174T tumours. In general, in LS174T tumours the distribution of Evans blue-albumin was uniform, whereas in HSTS 26T tumours the distribution was asymmetric. The asymmetric distribution of Evans blue-albumin in HSTS 26T tumours was observed in viable and necrotic regions. Large deposits of Evans-blue were associated with necrotic regions at distance from the infusion site, thus suggesting that necrotic areas could represent preferential pathways (higher K) and sinks for the accumulation of therapeutic agents (Figure 2A) . The non-uniform distribution of therapeutic agents could significantly limit the success of intratumoral infusions.
To increase K, enzymatic degradation of the interstitial matrix could be used. Degradation of the matrix with hyaluronidase increased K by ten-to 20-fold in muscle fascia (Day, 1952) , and by a factor of 24 in the lung (Lai Fook et al, 1989) . In a preliminary study, we measured K in vivo in two tumours following the intratumoral infusion (0.1 tl min-') of hyaluronidase. By least squares non-linear regression of the measured pressure profile, the values were 7.7 x 107 and 11.0 x 107 cm2/mmHg-' s. These two values are greater than the maximum values of K in the control group (Table 1) . Further studies are needed to evaluate the effect of enzyme digestion on K and on the IFP profiles in solid tumours.
In conclusion, we have developed a new technique to estimate K in vivo and after circulatory arrest in tumours with a spherically symmetrical distribution of the fluid infused. The precise spatial resolution of the micropipette technique provides a significant advantage over other techniques for estimating K in vivo. Most importantly the technique can be used to measure and manipulate fluid transport parameters in tumours to improve the delivery of therapeutic agents.
